Cargando…

T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation

The first successful European hematopoietic stem cell transplantation (HSCT) was performed in 1968 as treatment in a newborn with IL2RG deficiency using an HLA-identical sibling donor. Because of declining naive T and natural killer (NK) cells, and persistent human papilloma virus (HPV)-induced wart...

Descripción completa

Detalles Bibliográficos
Autores principales: Melsen, Janine E., van Ostaijen-ten Dam, Monique M., van den Akker, Erik B., Welters, Marij J. P., Heezen, Kim C., Pico-Knijnenburg, Ingrid, Kolijn, P. Martijn, Bredius, Robbert G. M., van Doorn, Remco, Langerak, Anton W., Schilham, Marco W., Lankester, Arjan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537207/
https://www.ncbi.nlm.nih.gov/pubmed/35527320
http://dx.doi.org/10.1007/s10875-022-01279-5
_version_ 1784803148480643072
author Melsen, Janine E.
van Ostaijen-ten Dam, Monique M.
van den Akker, Erik B.
Welters, Marij J. P.
Heezen, Kim C.
Pico-Knijnenburg, Ingrid
Kolijn, P. Martijn
Bredius, Robbert G. M.
van Doorn, Remco
Langerak, Anton W.
Schilham, Marco W.
Lankester, Arjan C.
author_facet Melsen, Janine E.
van Ostaijen-ten Dam, Monique M.
van den Akker, Erik B.
Welters, Marij J. P.
Heezen, Kim C.
Pico-Knijnenburg, Ingrid
Kolijn, P. Martijn
Bredius, Robbert G. M.
van Doorn, Remco
Langerak, Anton W.
Schilham, Marco W.
Lankester, Arjan C.
author_sort Melsen, Janine E.
collection PubMed
description The first successful European hematopoietic stem cell transplantation (HSCT) was performed in 1968 as treatment in a newborn with IL2RG deficiency using an HLA-identical sibling donor. Because of declining naive T and natural killer (NK) cells, and persistent human papilloma virus (HPV)-induced warts, the patient received a peripheral stem cell boost at the age of 37 years. NK and T cells were assessed before and up to 14 years after the boost by flow cytometry. The boost induced renewed reconstitution of functional NK cells that were 14 years later enriched for CD56(dim)CD27(+) NK cells. T-cell phenotype and T-cell receptor (TCR) repertoire were simultaneously analyzed by including TCR Vβ antibodies in the cytometry panel. Naive T-cell numbers with a diverse TCR Vβ repertoire were increased by the boost. Before and after the boost, clonal expansions with a homogeneous TIGIT and PD-1 phenotype were identified in the CD27(−) and/or CD28(−) memory population in the patient, but not in the donor. TRB sequencing was applied on sorted T-cell subsets from blood and on T cells from skin biopsies. Abundant circulating CD8 memory clonotypes with a chronic virus-associated CD57(+)KLRG1(+)CX3CR1(+) phenotype were also present in warts, but not in healthy skin of the patient, suggesting a link with HPV. In conclusion, we demonstrate in this IL2RG-deficient patient functional NK cells, a diverse and lasting naive T-cell compartment, supported by a stem cell boost, and an oligoclonal memory compartment half a century after HSCT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01279-5.
format Online
Article
Text
id pubmed-9537207
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-95372072022-10-08 T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation Melsen, Janine E. van Ostaijen-ten Dam, Monique M. van den Akker, Erik B. Welters, Marij J. P. Heezen, Kim C. Pico-Knijnenburg, Ingrid Kolijn, P. Martijn Bredius, Robbert G. M. van Doorn, Remco Langerak, Anton W. Schilham, Marco W. Lankester, Arjan C. J Clin Immunol Original Article The first successful European hematopoietic stem cell transplantation (HSCT) was performed in 1968 as treatment in a newborn with IL2RG deficiency using an HLA-identical sibling donor. Because of declining naive T and natural killer (NK) cells, and persistent human papilloma virus (HPV)-induced warts, the patient received a peripheral stem cell boost at the age of 37 years. NK and T cells were assessed before and up to 14 years after the boost by flow cytometry. The boost induced renewed reconstitution of functional NK cells that were 14 years later enriched for CD56(dim)CD27(+) NK cells. T-cell phenotype and T-cell receptor (TCR) repertoire were simultaneously analyzed by including TCR Vβ antibodies in the cytometry panel. Naive T-cell numbers with a diverse TCR Vβ repertoire were increased by the boost. Before and after the boost, clonal expansions with a homogeneous TIGIT and PD-1 phenotype were identified in the CD27(−) and/or CD28(−) memory population in the patient, but not in the donor. TRB sequencing was applied on sorted T-cell subsets from blood and on T cells from skin biopsies. Abundant circulating CD8 memory clonotypes with a chronic virus-associated CD57(+)KLRG1(+)CX3CR1(+) phenotype were also present in warts, but not in healthy skin of the patient, suggesting a link with HPV. In conclusion, we demonstrate in this IL2RG-deficient patient functional NK cells, a diverse and lasting naive T-cell compartment, supported by a stem cell boost, and an oligoclonal memory compartment half a century after HSCT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10875-022-01279-5. Springer US 2022-05-09 2022 /pmc/articles/PMC9537207/ /pubmed/35527320 http://dx.doi.org/10.1007/s10875-022-01279-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Melsen, Janine E.
van Ostaijen-ten Dam, Monique M.
van den Akker, Erik B.
Welters, Marij J. P.
Heezen, Kim C.
Pico-Knijnenburg, Ingrid
Kolijn, P. Martijn
Bredius, Robbert G. M.
van Doorn, Remco
Langerak, Anton W.
Schilham, Marco W.
Lankester, Arjan C.
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
title T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
title_full T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
title_fullStr T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
title_full_unstemmed T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
title_short T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation
title_sort t and nk cells in il2rg-deficient patient 50 years after hematopoietic stem cell transplantation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537207/
https://www.ncbi.nlm.nih.gov/pubmed/35527320
http://dx.doi.org/10.1007/s10875-022-01279-5
work_keys_str_mv AT melsenjaninee tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT vanostaijentendammoniquem tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT vandenakkererikb tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT weltersmarijjp tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT heezenkimc tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT picoknijnenburgingrid tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT kolijnpmartijn tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT brediusrobbertgm tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT vandoornremco tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT langerakantonw tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT schilhammarcow tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation
AT lankesterarjanc tandnkcellsinil2rgdeficientpatient50yearsafterhematopoieticstemcelltransplantation